Home/Filings/4/0001179110-19-001227
4//SEC Filing

McKee Blaine H. 4

Accession 0001179110-19-001227

CIK 0000855654other

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 4:35 PM ET

Size

5.2 KB

Accession

0001179110-19-001227

Insider Transaction Report

Form 4
Period: 2019-01-31
McKee Blaine H.
EVP & Chief Business Officer
Transactions
  • Award

    Stock Option (right to buy)

    2019-01-31$5.25/sh+173,140$908,985173,140 total
    Exercise: $5.25From: 2020-01-31Exp: 2029-01-31Common Stock (173,140 underlying)
Footnotes (1)
  • [F1]Exercisable in three equal installments over three years starting on the first year anniversary of the grant.

Issuer

IMMUNOGEN INC

CIK 0000855654

Entity typeother

Related Parties

1
  • filerCIK 0001669133

Filing Metadata

Form type
4
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 4:35 PM ET
Size
5.2 KB